Analysts Set Option Care Health, Inc. (NASDAQ:OPCH) Price Target at $37.27

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been assigned an average rating of “Moderate Buy” from the eleven research firms that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $37.2727.

A number of equities research analysts have recently commented on the stock. TD Cowen reiterated a “hold” rating on shares of Option Care Health in a research report on Tuesday, January 27th. Barrington Research raised their price objective on shares of Option Care Health from $38.00 to $42.00 and gave the stock an “outperform” rating in a research report on Friday, January 16th. Wall Street Zen cut shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Jefferies Financial Group restated a “buy” rating and set a $37.00 price objective on shares of Option Care Health in a research report on Tuesday, January 13th. Finally, National Bank Financial set a $37.00 price objective on shares of Option Care Health in a research report on Tuesday, January 27th.

Institutional Investors Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Durable Capital Partners LP increased its position in Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the last quarter. Fuller & Thaler Asset Management Inc. increased its position in Option Care Health by 12.1% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock worth $221,707,000 after purchasing an additional 752,058 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in Option Care Health by 6.2% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock worth $135,355,000 after purchasing an additional 247,118 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Option Care Health by 1.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,840,648 shares of the company’s stock worth $122,367,000 after purchasing an additional 44,252 shares during the last quarter. Finally, Morgan Stanley increased its position in Option Care Health by 13.3% during the fourth quarter. Morgan Stanley now owns 3,410,233 shares of the company’s stock worth $108,650,000 after purchasing an additional 400,740 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $28.82 on Monday. The firm has a 50-day simple moving average of $30.50 and a 200-day simple moving average of $30.74. The stock has a market capitalization of $4.52 billion, a price-to-earnings ratio of 22.52, a price-to-earnings-growth ratio of 1.61 and a beta of 0.95. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 0.87. Option Care Health has a 52 week low of $24.24 and a 52 week high of $36.80.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. The business had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.44 earnings per share. On average, equities analysts predict that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.